Elanco executive joins Neurizon board as observer
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neurizon Therapeutics Ltd (NUZ)
Neurizon Therapeutics Ltd stock price live, this page displays ASX NUZ stock exchange data. View the NUZ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Neurizon Therapeutics Ltd real time stock price chart below.
What Is the Neurizon Therapeutics Ltd Stock Price Today?
The Neurizon Therapeutics Ltd stock price today is 0.082.
What Is the Stock Symbol for Neurizon Therapeutics Ltd?
The stock symbol for Neurizon Therapeutics Ltd is "NUZ."
What Stock Exchange Does Neurizon Therapeutics Ltd Trade On?
Neurizon Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Neurizon Therapeutics Ltd a Good Stock to Buy?
Determining whether Neurizon Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NUZ quote. (ISIN: AU0000357261)
What Is the Neurizon Therapeutics Ltd Stock Price Today?
The Neurizon Therapeutics Ltd stock price today is 0.082.
What Is the Stock Symbol for Neurizon Therapeutics Ltd?
The stock symbol for Neurizon Therapeutics Ltd is "NUZ."
What Stock Exchange Does Neurizon Therapeutics Ltd Trade On?
Neurizon Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Neurizon Therapeutics Ltd a Good Stock to Buy?
Determining whether Neurizon Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NUZ quote. (ISIN: AU0000357261)
0.082
+0.001(+1.23%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.081
0.084
52 wk Range
0.079
0.185
NUZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0810.084
52 wk Range
0.0790.185
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
NUZ Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.390
Upside
+375.61%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Neurizon Therapeutics Ltd Company Profile
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Compare NUZ to Peers and Sector
Metrics to compare | NUZ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNUZPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.0x | −5.5x | −0.6x | |
PEG Ratio | 0.05 | −0.04 | 0.00 | |
Price/Book | 17.9x | 5.7x | 2.6x | |
Price / LTM Sales | 32.8x | 27.9x | 3.4x | |
Upside (Analyst Target) | 375.6% | 144.8% | 41.1% | |
Fair Value Upside | Unlock | 0.7% | 5.3% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.390
(+375.61% Upside)
Earnings
Latest Release
Aug 25, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
6.40K / --
FAQ
What Is the Neurizon Therapeutics (NUZ) Stock Price Today?
The Neurizon Therapeutics stock price today is 0.082
What Stock Exchange Does Neurizon Therapeutics Trade On?
Neurizon Therapeutics is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for Neurizon Therapeutics?
The stock symbol for Neurizon Therapeutics is "NUZ."
What Is the Neurizon Therapeutics Market Cap?
As of today, Neurizon Therapeutics market cap is 50.44M.
What Is Neurizon Therapeutics's Earnings Per Share (TTM)?
The Neurizon Therapeutics EPS (TTM) is -0.03.
From a Technical Analysis Perspective, Is NUZ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Neurizon Therapeutics Stock Split?
Neurizon Therapeutics has split 6 times.
How Many Employees Does Neurizon Therapeutics Have?
Neurizon Therapeutics has 4 employees.
What is the current trading status of Neurizon Therapeutics (NUZ)?
As of Jan 19, 2026, Neurizon Therapeutics (NUZ) is trading at a price of 0.082, with a previous close of 0.082. The stock has fluctuated within a day range of 0.081 to 0.084, while its 52-week range spans from 0.079 to 0.185.
What Is Neurizon Therapeutics (NUZ) Price Target According to Analysts?
The average 12-month price target for Neurizon Therapeutics is AUD0.39, with a high estimate of AUD0.39 and a low estimate of AUD0.39. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +375.61% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.